drugset / Trial / NCT00577395

Bone Microarchitecture in Osteopenic Postmenopausal Women

NCT00577395

Phase 4 Terminated 13 enrolled Warner Chilcott Sanofi · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to compare the difference in bone microarchitecture of the distal radius at month 12 in postmenopausal osteopenic women treated with risedronate 150mg taken once a month compared to placebo.

Timeline

Start
2008-07
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Risedronate Small molecule 150 mg Oral

Indications